Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02065466
Title Combo of Abraxane, TMZ, Bevacizumab in Metastatic Melanoma With Brain Metastases
Recruitment Withdrawn
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors University of Arizona
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Arizona Cancer Center at University of Arizona Health Sciences Center Tucson Arizona 85724-5024 United States Details
University of Arizona Cancer Center Tucson Arizona 85742 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field